# Johnson & Johnson news releases

- **Website:** https://www.jnj.com
- **Location:** Beerse, Belgium
- **Releases:** 1
- **First release:** November 20, 2026
- **Most recent:** November 20, 2026
- **Categories:** General
- **Web page:** https://www.connectively.us/news-releases/johnson-and-johnson
- **RSS:** https://www.connectively.us/news-releases/johnson-and-johnson/rss.xml

## Releases

### [Late-breaking Johnson & Johnson data in psoriatic arthritis (PsA) shows TREMFYA® (guselkumab) is the only advanced therapy to demonstrate MRI-confirmed improvements in spinal pain and stiffness](https://www.connectively.us/news-releases/late-breaking-johnson-and-johnson-data-in-psoriatic-arthritis-psa-2)

November 20, 2026 · General

TREMFYA® (guselkumab) showed statistically significant improvement in disease activity on the BASDAI score versus placebo, reflecting meaningful reductions in pain, stiffness, swelling and fatigue in a Phase 4 study1,2 Guselkumab demonstrated more than 2 times greater reduction…
